Pfizer is paying $47.50 a share in cash for Metsera, a 43% premium on the startup’s closing price on Friday that gives the ...
Wachtell guides Pfizer as it scrambles to win a slice in booming obesity drug market with Paul Weiss-repped Metsera ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results